Navigation Links
Visions: Innovating like Madonna and Willie Nelson (and Steve Jobs)

Oren Harari
Milwaukee, Wis. - Oren Harari is coming to Milwaukee next week for a very simple reason - to convey the importance of innovation.

Not just to manufacturers, who he will be addressing at the state's annual Manufacturing Matters conference
Full article >>> e common threads, anxieties, and challenges. He also discovered that the convergence of forces like deregulation, globalization, technological advances, transparency, and fragmentation are leading to increased commoditization of products and increased imitation of services, regardless of industry.

Having gleaned all that, he came up with a label - the copycat economy - for which relentles......

Full article >>> /ipod/ipod.html">iPod and iTunes platform, he demonstrated how to reinvent products, services, and value propositions by looking into the horizon and capitalizing on opportunities that aren't in your face yet, but one day will be, Harari said.

In the book, he explains how a number of businesses, publicly and privately held, defy convention and break from the pack in unorthodox ways th......

Full article >>>
'"/>

Source:wistechnology.com By Joe Vanden Plas 04/16/07


Related biology technology :

1. Visions: Broderick says Wisconsin should be in top third in venture capital
2. Visions: Chicago software exec Jason Fried breaks (almost) all the rules
3. Visions: Preizler offers insurers perspective on healthcare IT
4. Visions: Matheys says CIO role is good training for executive suite
5. Visions: IT exec says CIOs must be ready to help companies ramp up trade
6. Visions: Wade offers straight talk on e-medical records
7. Visions: Benson touts embedded innovation
8. Visions: Carbone bullish on Wisconsin venture capital
9. Visions: Rimas Buinevicius, CEO of Sonic Foundry
10. WTN Visions: Convergence is changing business
11. Hey Willie, Wisconsin Manufacturing Doesnt Need an Aid Concert!
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:6/27/2016)... 2016  Liquid Biotech USA ... a Sponsored Research Agreement with The University of ... from cancer patients.  The funding will be used ... with clinical outcomes in cancer patients undergoing a ... be employed to support the design of a ...
(Date:6/24/2016)... 2016 Epic Sciences unveiled a liquid ... to PARP inhibitors by targeting homologous recombination deficiency ... new test has already been incorporated into numerous ... types. Over 230 clinical trials are ... including PARP, ATM, ATR, DNA-PK and WEE-1. Drugs ...
(Date:6/23/2016)... ... June 23, 2016 , ... Mosio, ... second eBook, “Clinical Trials Patient Recruitment and Retention Tips.” Partnering with experienced clinical ... eBook by providing practical tips, tools, and strategies for clinical researchers. , “The ...
(Date:6/23/2016)... , June 23, 2016 /PRNewswire/ - FACIT has ... Ontario biotechnology company, Propellon Therapeutics Inc. ... and commercialization of a portfolio of first-in-class WDR5 ... targets such as WDR5 represent an exciting class ... in precision medicine for cancer patients. Substantial advances ...
Breaking Biology Technology:
(Date:6/15/2016)... , June 15, 2016 ... market report titled "Gesture Recognition Market by Application Market - Global ... 2016 - 2024". According to the report, the  global ... billion in 2015 and is estimated to grow ... 48.56 billion by 2024.  Increasing application ...
(Date:6/7/2016)... , June 7, 2016  Syngrafii Inc. and ... business relationship that includes integrating Syngrafii,s patented LongPen™ ... project. This collaboration will result in greater convenience ... credit union, while maintaining existing document workflow and ... ...
(Date:6/2/2016)... The Weather Company , an IBM Business (NYSE: IBM ... which consumers will be able to interact with IBM Watson ... or text and receive relevant information about the product or ... long sought an advertising solution that can create a one-to-one ... valuable; and can scale across millions of interactions and touchpoints. ...
Breaking Biology News(10 mins):